Utilization of Cyclocreatine Phosphate, an Analogue of Creatine Phosphate, by Mouse Brain During Ischemia and Its Sparing Action on Brain Energy Reserves
The DOI matches its Crossref record.
Abstract
Brains of mice fed the creatine analogue cyclocreatine accumulated 10 γmol/g fresh wt. of cyclocreatine, of which 93% occurred as the synthetic phosphagen, cyclocreatine‐P (l‐carboxymethyl‐2‐imino‐3‐phosphonoimidazolidine). In brains containing cyclocreatine‐P 2‐, creatine‐P (phosphocreatine) levels were lowered 40%; levels of ATP, P 1, and glucose were not altered: glutamate levels were lowered 17%: and aspartate levels were lowered 56%, relative to controls. When cyclocreatine was removed from the diet, brain cyclocreatine levels decreased with a half‐life of 17 to 28 days. Ischemia was initiated in brains by decapitation of mice previously injected with the centrally acting muscle relaxant mephenesin. The initial creatine‐P pool of 2‐3 γmol/g was completely depleted within 1 min in ischemic brains of both control and cyclocreatine‐fed mice. In brains of cyclocreatine‐fed mice, the much larger cyclocreatine‐P pool of 9.3 γmol/g decreased to 6 γmol/g after 2 min and to 2.2 γrnol/g after 4 min of ischemia, with a correspondingly increased accumulation of P 1. Levels of total cellular ATP were sustained slightly longer during ischemia in brains containing cyclocreatine‐P. Available energy reserves of control brains were almost completely depleted after 2 min of ischemia, whereas generation and utilization of high‐energy phosphate continued for more than 3 min after initiation of ischemia in brains of cyclocreatine‐fed mice. These data suggest that during ischemic episodes cyclocreatine‐P can function as a supplemental reservoir of high‐energy phosphate and prolong the time required to exhaust the available energy stores of ischemic brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950
Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism
Wyss, M., Smeitink, J., Wevers, R. A., & Wallimann, T. (1992) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(92)90096-k · Cited by 447
Neuroprotective Effects of Creatine and Cyclocreatine in Animal Models of Huntington’s Disease
Matthews, R. T., Yang, L., Jenkins, B. G., Ferrante, R. J., Rosen, B. R., Kaddurah-Daouk, R., & Beal, M. F. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00156.1998 · Cited by 430
Creatine and Cyclocreatine Attenuate MPTP Neurotoxicity
Matthews, R. T., Ferrante, R. J., Klivenyi, P., Yang, L., Klein, A. M., Mueller, G., Kaddurah-Daouk, R., & Beal, M. F. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7049 · Cited by 373
Mitochondrial Approaches for Neuroprotection
Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294
Metadata
- Authors
- Woznicki, D. T., & Walker, J. B.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 1980-05
- Volume
- 34
- Issue
- 5
- Pages
- 1247-1253
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2078958804
- Cited by
- 42
- References
- 0
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Utilization of Cyclocreatine Phosphate, an Analogue of Creatine Phosphate, by Mouse Brain During Ischemia and Its Sparing Action on Brain Energy Reserves. https://app.cochat.ai/papers/10.1111/j.1471-4159.1980.tb09966.x
- The paper
- Woznicki, D. T., & Walker, J. B. (1980). Utilization of Cyclocreatine Phosphate, an Analogue of Creatine Phosphate, by Mouse Brain During Ischemia and Its Sparing Action on Brain Energy Reserves. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.1980.tb09966.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.